Drugs & medicalClass II

Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

Failed Dissolution Specifications

Read the official notice →
Date
2024-05-01
Country
United States
Brand
Glenmark Pharmaceuticals
Product
Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for:…
Classification
Class II
Units
Nationwide in the USA.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Glenmark Pharmaceuticals recalls

  1. 2024-07-24
  2. US
  3. US
  4. 2024-06-12
  5. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark…

    CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUS Nationwide.Official notice →
  6. 2024-04-10
  7. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

    Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USOfficial notice →
  8. 2024-01-31
  9. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark…

    Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA NationwideOfficial notice →
  10. 2023-12-06
  11. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa…

    Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwideOfficial notice →
All 43 Glenmark Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2024-05-01
  2. US
    Drugs & medicalClass I

    Biomerieux Inc recalls VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) AST-GN95, REF…

    Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for isolates that have a result…

    FDA · DeviceBiomerieux IncWorldwideOfficial notice →
  3. US
    Drugs & medicalClass II

    LEICA BIOSYSTEMS NUSSLOCH GMBH recalls Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)

    There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or…

    FDA · DeviceLEICA BIOSYSTEMS NUSSLOCH GMBHUS, NationwideOfficial notice →
  4. US
    Drugs & medicalClass II

    EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited,…

    CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

    FDA · DrugEPI Health, LLCUS NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30…

    Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

    FDA · DrugCipla USA, Inc.USA nationwide.Official notice →
  6. US
    Drugs & medicalClass I

    FA Online Inc recalls ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.

    Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.

    FDA · DrugFA Online IncUSA Nationwide. The product was sold via Amazon Market Place.Official notice →
  7. US
    Drugs & medicalClass III

    Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America…

    Cross Contamination with Other Products

    FDA · DrugSecond Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.USA nationwide.Official notice →
See all drugs & medical recalls →